Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beijing Saimo Technology Co., Ltd. Share Issue/Capital Change 2025

Apr 25, 2025

50681_rns_2025-04-25_58f16047-d5ad-4801-8fdc-276eb98af4b8.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

img-0.jpeg

Beijing Saimo Technology Co., Ltd.

北京賽目科技股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 2571)

PROPOSED ADOPTION OF H SHARE AWARD SCHEME

PROPOSED AUTHORISATION TO THE BOARD AND/OR AUTHORISED
PERSONS TO HANDLE MATTERS RELATING TO THE H SHARE
AWARD SCHEME

PROPOSED ADOPTION OF H SHARE AWARD SCHEME

The board (the "Board") of directors (the "Director(s)") of Beijing Saimo Technology Co., Ltd. (the "Company", together with its subsidiaries, collectively referred to as the "Group") is pleased to announce that, on 25 April 2025, the Board has resolved to propose the adoption of the 2025 H Share Award Trust Scheme (the "H Share Award Scheme") of the Company.

The H Share Award Scheme aims to attract, motivate and retain outstanding technical R&D talent, management professionals, and business elites, aligning their interests with those of the shareholders (the "Shareholders") of the Company and the Group as a whole to ensure the smooth implementation and realisation of the development strategy and operating objectives of the Company, thereby fostering sustained, stable, and rapid growth of the Company.

The H Share Award Scheme constitutes a scheme involving the existing shares of the Company as referenced under Chapter 17 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"), and shall be subject to the applicable disclosure requirements under Rule 17.12 of the Listing Rules. However, the H Share Award Scheme does not constitute a share scheme involving the issue of new shares or the grant of options over any new securities of the Company under Chapter 17 of the Listing Rules. Therefore, the adoption of the H Share Award Scheme is not subject to the approval of the Shareholders pursuant to the Listing Rules. Nevertheless, pursuant to the Articles of Association of the Company, the H Share Award Scheme and the related matters are subject to, among others, the approval of the Shareholders at the general meeting of the Company.


  • 2 -

PROPOSED AUTHORISATION TO THE BOARD AND/OR AUTHORISED PERSONS TO HANDLE MATTERS RELATING TO THE H SHARE AWARD SCHEME

To ensure the successful implementation of the H Share Award Scheme, the Board proposes that, subject to the approval from the Shareholders of the H Share Award Scheme at the general meeting, the Shareholders shall also authorise the Board and/or authorised persons to handle matters relating to the H Share Award Scheme at their sole discretion. The details of such authorisation will be set out in the circular to be despatched to Shareholders thereafter.

The proposed adoption of the H Share Award Scheme and the proposed authorisation to the Board and/or authorised persons to handle matters relating to the H Share Award Scheme shall be subject to the approval of the Shareholders at the general meeting of the Company.

A circular containing, among other things, the details and key terms of the H Share Award Scheme and the authorisation details will be despatched to the Shareholders in due course.

By order of the Board
Beijing Saimo Technology Co., Ltd.
Hu Dalin
Chairman of the Board and Executive Director

Hong Kong, 25 April 2025

As at the date of this announcement, the executive Directors are Mr. Hu Dalin, Mr. He Feng and Ms. Ma Lei, the non-executive Directors are Dr. Kan Zhigang, Dr. Yao Xiang and Ms. Gong Xiao; and the independent non-executive Directors are Ms. Guo Lili, Mr. Huang Hua and Mr. Wong Ho Kwan.